Autoimmune Disease Diagnostics: Global Markets

Jan 2024| PHM160C| BCC Publishing

Report Highlights

The global market for autoimmune disease diagnostics is estimated to increase from $14.8 billion in 2023 to reach $17.9 billion by 2028, at a compound annual growth rate (CAGR) of 3.9% from 2023 through 2028.

Report Includes

  • 41 data tables and 30 additional tables
  • An overview of the global market landscape related to the autoimmune disease diagnostics
  • In-depth analysis of global market trends, featuring historical revenue data for 2020-2022, estimated figures for 2023, as well as forecasts for 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
  • Evaluation of the current market size and revenue growth prospects specific to autoimmune disease diagnostics, accompanied by a comprehensive market share analysis categorized by technology, indication, gender, and geographical region
  • Detailed description of autoimmune disorder & therapies, and causes such as intrinsic factors, environmental factors, and lifestyle factors, and insights into new diagnostic pathway for autoimmune and inflammatory disorders
  • Discussion on role of bioinformatics and biomarkers on autoimmune disorder therapies and information on standardization of test results
  • Coverage of new product launches in the therapeutics for autoimmune diseases and performance methods in the detection of autoimmune antibodies
  • Coverage of emerging technologies in autoimmune disease diagnostics, recent developments, future opportunities, patent review, and ESG trends
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
  • Detailed profiles of leading market participants, including Abbott, Beckman Coulter Inc., BioMérieux, Siemens Healthcare, F. Hoffmann-La Roche AG, and Thermo Fisher Scientific

Report Scope

This report aims to study the autoimmune disease diagnostics global market size comprehensively. Current and historical market revenues can be estimated based on the technology, by indication, gender and region.

Frequently Asked Questions (FAQs)

The global Autoimmune disease diagnostics market is projected to grow from $14.2 billion in 2022 to $17.9 billion in 2028 at a compound annual growth rate (CAGR) of 3.9 % during the forecast period.
The Autoimmune disease diagnostics market is experiencing growth driven by technological advancements. The heightened awareness among medical practitioners and patients is crucial in facilitating prompt diagnosis and intervention. Moreover, the rising prevalence of autoimmune diseases, such as rheumatoid arthritis, is fueling the demand for a broader range of treatment options. Ongoing research efforts and collaborative initiatives also significantly deepen the understanding of therapeutics, promoting innovation within the field.
The Autoimmune disease diagnostics market is segmented based on the product type, such as technology, indication, and geographic region and gender.
The Enzyme-linked immunosorbent assay (ELISA) segment will dominate the market by the end of 2028.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2023-2028
Base year market size $14.2 billion
Market size forecast $17.9 billion
Growth rate CAGR of 3.9% for the forecast period of 2023-2028
Units considered $ Millions
Segments covered Technology, Indication, Gender, and Geographic Region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World
Countries covered U.S., Canada, Mexico, Germany, France, UK, Italy, Spain, China, India, Japan, Australia, New Zealand, Brazil, and South Africa
Key Market Drivers
  • Increasing awareness and early diagnosis of disease.
  • Government initiatives and funding.
  • International expansion.
Companies studied
  • ABBOTT
  • BD BIOSCIENCES
  • BECKMAN COULTER (SUBSIDIARY OF DANAHER CORP.)
  • BIOMERIEUX
  • BIO-RAD LABORATORIES INC.
  • F. HOFFMANN-LA ROCHE LTD.
  • QUEST DIAGNOSTICS INC.
  • SIEMENS HEALTHINEERS AG
  • THERMO FISHER SCIENTIFIC INC.

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Autoimmune Disease Diagnostics: Global Markets110Free
Chapter- 1: Introduction4Free
Chapter- 2: Summary and Highlights3Free
Chapter- 3: Market Overview and Definitions18Free
Chapter- 4: Market Dynamics4Free
Chapter- 5: Market Breakdown by Region9Free
Chapter- 6: Market Breakdown by Gender6Free
Chapter- 7: Market Breakdown by Indication9Free
Chapter- 8: Market Breakdown by Technology7Free
Chapter- 9: ESG Development9Free
Chapter- 10: Emerging Trends and Technologies2Free
Chapter- 11: Competitive Landscape2Free
Chapter- 12: Patent Analysis3Free
Chapter- 13: Pipeline Analysis15Free
Chapter- 14: M&A and Venture Funding Outlook2Free
Chapter- 15: Company Profiles16Free
Chapter- 16: Appendix: Acronyms1Free
Published - Sep-2021| Analyst - BCC Publishing| Code - PHM160B

Report Highlights

The global market for autoimmune disease diagnostics should grow from $13.7 billion in 2021 to $17.0 billion by 2026 with a compound annual growth rate (CAGR) of 4.4% for the period of 2021-2026.

Report Includes

  • 37 data tables and 33 additional tables
  • An overview of the global market for autoimmune disease diagnostics
  • Estimation of the market size and analyses of the global market trends, with data from 2019, 2020 estimates for 2021 with projection of CAGR through 2026
  • Market share analysis of autoimmune disease diagnostics based on technology, indication, region and gender and identification of new opportunities, challenges, and technological changes within the industry
  • Detailed description of autoimmune disorder & therapies, and causes such as intrinsic factors, environmental factors, and lifestyle factors, and insights into new diagnostic pathway for autoimmune and inflammatory disorders
  • Discussion on role of bioinformatics and biomarkers on autoimmune disorder therapies and information on standardization of test results
  • Coverage of new product launches in the therapeutics for autoimmune diseases and performance methods in the detection of autoimmune antibodies
  • Detailed analysis of the current market trends, market forecast, and discussion of technological, and regulatory elements that are affecting the future marketplace
  • Comprehensive company profiles of major players in the industry, including Biomerieux, Thermo Fisher Scientific, Siemens Healthcare Diagnostics, Beckman Coulter, Becton Dickinson  and Abbott
Published - Sep-2014| Analyst - Anandi Karumbati| Code - PHM160A

Report Highlights

The global market value for autoimmune disease diagnostics for 2013 was valued at $11.9 billion. This is expected to reach about $12.1 billion in 2014 and $13.1 billion in 2019, with a compound annual growth rate (CAGR) of 1.6% for the five-year period, 2014 to 2019.

Report Includes

  • An overview of the global market for autoimmune disease diagnostics.
  • Analyses of global market trends, with data from 2012 and 2013, estimates for 2014, and projections of CAGRs through 2019.
  • Segmentation of the market by disease, by geographical location, and by gender.
  • Industry analysis with focuses on customers, suppliers, competitors, new entrants, substitutes, and complements.
  • Comprehensive company profiles of major players in the industry.

Autoimmune Disease Diagnostics: Global Markets

Single User License: $5500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS